Abstract:Non-small cell lung cancer is the most common pathological type of lung cancer. Along with the rising incidence in recent years, lung cancer has been the leading cause of death due to malignancies both in our country and worldwide. Due to simplistic therapeutic approach for lung cancer decades ago, those patients suffering from advanced lung cancer had short lifetime, and it was difficult to ensure their life quality. In recent years, many molecular targeted drugs, such as Gefitinib, Erlotinib and Crizotinib etc., have been successively applied in clinical use, and they bring about a substantial prolongation of survival life and improvement in life quality of those patients with advanced lung cancer. In 2014, there was a number of important reports concerning the diagnosis and treatment of non-small cell lung cancer in the annual meetings of either American Society of Clinical Oncology or European Society for Medical Oncology. On the basis of the relevant reports delivered in the conferences, it is our attempt to summarize the recent advances in regard to chemotherapy, molecular targeted therapy, measures to treat TKI therapy resistant cases, and immune therapy, followed by a comment regarding recent advances in the treatment of non-small cell lung cancer in 2014. DOI: 10.11855/j.issn.0577-7402.2015.01.03

The advances on interstitial lung disease associated with molecular targeted drugs

Advance in treatment of interstitial lung disease

Recent Advancement of Interstitial Lung Disease in Molecular Genetics

Cancer therapy-related interstitial lung disease

Targeted therapy and precision medicine for lung cancer

Research advance on interstitial lung disease associated cough

Advance on Targeted Therapy for the Treatment of Non-Small Cell Lung Cancer

Radiation-induced lung injury: latest molecular developments, therapeutic approaches, and clinical guidance

Recent Advances in the Study of Bioreductive Drugs Targeted Tumor Hypoxia

Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review

Nintedanib Effect in Cancer Patients with Interstitial Lung Disease Induced by Targeted Therapies and Immunotherapies

Progress in molecular targets and associated drugs for lung cancer treatment

[Clinical Advances in Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma].

[A Review of Drug Therapy of Lung Cancer with Interstitial Lung Disease].

Pathogenic mechanisms and latest therapeutic approaches for radiation-induced lung injury: A narrative review

Medical Treatment of Advanced Non-Small Cell Lung Cancer: Progress in 2014

Radionuclide Molecular Target Therapy for Lung Cancer

Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancer.

Advances on Molecular Targeted Anti-Tumor Drugs

FUSCC criteria for the management of targeted drug-induced interstitial lung disease in solid tumors

Recent progress in targeted therapy for non-small cell lung cancer